Filing Details
- Accession Number:
- 0001055726-21-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-09 19:03:30
- Reporting Period:
- 2021-03-05
- Accepted Time:
- 2021-03-09 19:03:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1055726 | Inovio Pharmaceuticals Inc. | INO | Surgical & Medical Instruments & Apparatus (3841) | 330969592 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1669080 | B. David Weiner | 660 W. Germantown Pike Suite 110 Plymouth Meeting PA 19462 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-05 | 11,666 | $0.00 | 838,885 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-08 | 3,500 | $9.18 | 835,385 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-03-08 | 11,667 | $0.00 | 847,052 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-09 | 3,500 | $9.60 | 843,552 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2021-03-05 | 11,666 | $0.00 | 11,666 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2021-03-08 | 11,667 | $0.00 | 11,667 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 11,666 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares vested on March 5, 2021. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of restricted stock units granted by the issuer.
- Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares will vest on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Billionaire Hedge Funds
